Genmab

Genmab shares rise on cancer drug's FDA license application
Yahoo/Reuters
Mon, 06/8/15 - 10:07 am
Genmab
FDA
JNJ
daratumumab
Multiple Myeloma
Amgen hands off an IL-15 drug--strings attached--for upstart effort on celiac disease
Fierce Biotech
Mon, 03/2/15 - 08:14 am
Amgen
celiac disease
AMG 714
Genmab
JNJ launches PhII lymphoma study for daratumumab
Fierce Biotech
Thu, 12/4/14 - 04:13 pm
JNJ
lymphoma
daratumumab
Genmab
non-Hodgkin's lymphoma
J&J hands over $25M milestone for daratumumab progress
Fierce Biotech
Mon, 07/7/14 - 11:25 am
JNJ
daratumumab
Genmab
Glaxo, Genmab report phase III ofatumumab study did not meet primary endpoint
The Fly on the Wall
Mon, 05/19/14 - 03:17 pm
GSK
Genmab
ofatumumab
large B-cell lymphoma
Genmab earnings boosted by Janssen collaboration
Yahoo/Reuters
Wed, 05/7/14 - 03:30 pm
Genmab
earnings
Janssen
Denmark's Genmab expands biotech collaboration with Janssen
Reuters
Wed, 12/4/13 - 11:44 am
Genmab
Janssen
Duobody antibodies
Milestone payment triggers Genmab guidance increase
Yahoo/Reuters
Tue, 11/26/13 - 09:00 am
Genmab
daratumumab
JNJ
Janssen
GSK/Genmab file Arzerra for first-line CLL
Pharma Times, UK
Mon, 10/21/13 - 09:56 am
Arzerra
GSK
Genmab
CLL
chronic lymphocytic leukemia
Genmab announces positive results for sclerosis drug candidate
Reuters
Thu, 10/10/13 - 06:19 pm
Genmab
MS
multiple sclerosis
ofatumumab
GSK and Genmab Announce European Submission to Regulatory Authorities for Arzerra(R) (Ofatumumab) as 1st Line Treatment of Chronic Lymphocytic Leukemia (CLL)
Yahoo/Globe Newswire
Sat, 10/5/13 - 09:31 am
ofatumumab
GSK
Genmab
Arzerra
leukemia
chronic lymphocytic leukemia
Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia?
Motley Fool
Wed, 09/18/13 - 10:34 am
chronic lymphocytic leukemia
Sanofi
Campath
GSK
Arzerra
Roche
Rituxan
ibrutinib
Pharmacyclics
obinutuzumab
JNJ
Genmab
Breakthrough status for GSK and Genmab leukemia drug
Pharma Times, UK
Mon, 09/16/13 - 10:14 am
GSK
Genmab
breakthrough therapies
Arzerra
chronic lymphocytic leukemia
FDA
These 2 Companies Are the Biggest Winners of the FDA's Breakthrough Designation
Motley Fool
Tue, 09/3/13 - 09:33 am
FDA
breakthrough therapies
ibrutinib
Pharmacyclics
JNJ
Novartis
LDK378
serelaxin
daratumumab
Genmab
Genmab shares tumble after fund sells shares
Reuters
Tue, 06/11/13 - 09:13 am
Genmab
Johnson & Johnson's Potential Blockbuster For Multiple Myeloma And Its Competitors
Seeking Alpha
Tue, 06/4/13 - 09:36 am
JNJ
Multiple Myeloma
daratumumab
Genmab
Genmab Rises After FDA Grants Breakthrough Status to Cancer Drug
Bloomberg
Thu, 05/2/13 - 10:31 am
Genmab
FDA
JNJ
daratumumab
Multiple Myeloma
Genmab Rises as Nordea Says Bet on Cancer Drug: Copenhagen Mover
Bloomberg
Wed, 03/20/13 - 12:09 pm
Genmab
JNJ
daratumumab
Multiple Myeloma
New anti-inflammatory causes stir at ACC
Pharma Times, UK
Mon, 03/11/13 - 11:00 am
anti-inflammatories
Genmab
Roche
inclacumab
angioplasty
Genmab Rises as Danske Sees FDA Breakthrough: Copenhagen Mover
Bloomberg
Fri, 02/15/13 - 10:58 am
Genmab
FDA
daratumumab

Pages